Candel Therapeutics (CADL) Interest & Investment Income: 2020-2024
Historic Interest & Investment Income for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $1.1 million.
- Candel Therapeutics' Interest & Investment Income fell 48.38% to $415,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year increase of 99.71%. This contributed to the annual value of $1.1 million for FY2024, which is 47.81% down from last year.
- Latest data reveals that Candel Therapeutics reported Interest & Investment Income of $1.1 million as of FY2024, which was down 47.81% from $2.1 million recorded in FY2023.
- Candel Therapeutics' Interest & Investment Income's 5-year high stood at $2.1 million during FY2023, with a 5-year trough of -$53,000 in FY2021.
- In the last 3 years, Candel Therapeutics' Interest & Investment Income had a median value of $1.2 million in 2022 and averaged $1.5 million.
- As far as peak fluctuations go, Candel Therapeutics' Interest & Investment Income crashed by 147.75% in 2021, and later spiked by 2,398.11% in 2022.
- Over the past 5 years, Candel Therapeutics' Interest & Investment Income (Yearly) stood at $111,000 in 2020, then plummeted by 147.75% to -$53,000 in 2021, then soared by 2,398.11% to $1.2 million in 2022, then surged by 70.85% to $2.1 million in 2023, then plummeted by 47.81% to $1.1 million in 2024.